MyFirstApp Sweden AB

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0020541589
SEK
4.41
-0.58 (-11.62%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About MyFirstApp Sweden AB stock-summary
stock-summary
MyFirstApp Sweden AB
Pharmaceuticals & Biotechnology
ObsteCare AB is a Sweden-based provider of solutions within area of childbirth care. The Company is a developer of Amniotic Fluid Lactate (AFL) method, which aims to measure lactic acid content in the fetal water. Samples of amniotic fluid are collected and analyzed for the concentration of lactate. The lactate level is automatically presented in the partogram. By combining the result with the development of cervix dilatation a thorough understanding of the delivery status is obtained. The fluid is collected with a standard syringe. The fluid is delivered into the single use measuring probe on the measuring unit and the measurement starts automatically. The method is used by clinics primarily in the Nordic countries, the United Kingdom and the Baltic States.
Company Coordinates stock-summary
Company Details
Fogdevreten 2 , SOLNA None : 171 65
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Mar 2025)
Net Profit:
-1 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

SEK 164 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.01

stock-summary
Return on Equity

-444.23%

stock-summary
Price to Book

49.68